back to overview


MTIP Healthcare Clinic 2019

April 18, 2019 + Jessica Di Palo
5 Min read

Basel, April 9th, 2019 MTIP presented its journey in the healthtech sector with its insights on the current industry developments, its great portfolio and an exciting outlook of the future with MTIP Fund ll.

The MTIP Healthcare Clinic 2019 took place in the Victoria Hotel Basel. The guests were welcomed by MTIP’s chairman Dr. Felix Grisard and in the following overview, Dr. Christoph Kausch enlightened the invited audience about MTIP’s main differentiators. MTIP is one of the leading European investors in Healthtech and connects the traditional healthcare sector with new technologies, emerging from the IT sector. By being one of the least digitalized sectors and decreasing productivity over the last couple of years, healthcare strives for improvements. Digitalization in healthcare is just emerging and offers enormous opportunities which are mainly uncorrelated to the traditional financial markets and therefore offer a highly attractive risk-reward profile for investors.

Based on this, Dr. Claudia Colciago presented MTIP’s view on future developments in the healthcare sector and emphasized the importance of investing in companies with a strong and sustainable growth trajectory. Artificial intelligence will have a major impact on healthcare, but AI technology can only be leveraged if a robust framework to collect, structure, and share data is established beforehand. In the future, Digital Health companies will help in delivering affordable and efficient care to patients all around the globe.

Speaking about excellent examples of affordable and efficient care, MTIP’s portfolio was presented by the investment partner David Germonpré. Last year’s new investments Quanta Dialysis, Lumeon and Cynerio were presented by their respective management team. Thanks to their expertise, the audience had a deep dive into several hot topics around chronic diseases, decentralized care, optimization of treatment delivery and cybersecurity.

MTIP was able to establish this great portfolio in under three years and more is coming. The future steps and the key terms of the MTIP Fund II concluded the presentations. The audience was fascinated by MTIP’s development and engaged in insightful discussion during the Apéro riche, enjoying a stunning view over Basel.

Share the Article


SFDR Art. 8 or Art. 9? What’s the difference?

SFDR: getting the terminology right


MTIP participates in Oviva’s new $80m Series C funding

Oviva raises $80 million financing round


MTIP invests in Intelligencia to reduce the risk of clinical research through artificial intelligence

MTIP's new investment in Intelligencia


Private Equity 101: Part one – Glossary

Are you new to the healthtech space?


Leading brands revolutionize care journeys with Lumeon

How Lumeon orchestrates care journey


Trialbee – our hero in patient matching and recruiting for clinical trials

Trialbee - patient matching and recruiting

news blog

Digital healthcare: patient-first?

Digital Healthcare Report 2021 in collaboration with Dealroom and INKEF Capital

SFDR – How does MTIP approach the EU’s Sustainable Disclosure Regulation?

New SFDR obligations


MTIP Announces Strong First Closing of Fund II to drive Healthtech Innovation

First Closing of Fund II


How to pitch to a healthtech Investor

Blog Pitching


MTIP invests in Koa Health to make mental health treatment more accessible

New investment in Koa Health


MTIP scored fantastic grades in the UNPRI assessment report of 2020

UNPRI Report grades 2020


4 Health VCs Share Their Business Priorities and What is Next

Interview Techtour


MTIP invests in Trialbee

New investment in Trialbee


TytoCare closes $50 million round as the demand for telehealth accelerates

TytoCare closes new round


The digital healthtech sector is expanding – and so are we!

Two new empolyees start in April


MTIP has sucessfully exited Blueprint Genetics

Blueprint exit January 2020


New MTIP investment in Oviva

New investment in Oviva


Whitepaper: A positive prognosis for the future of healthtech

Our first Whitepaper


Elite Summit 2019 – Interview with our Managing Partner Christoph Kausch

Elite Summit 2019


MTIP Healthcare Clinic 2019

Healthcare clinic 2019

New MTIP investment in Cynerio

New investment in Cynerio


MTIP invests in Lumeon Ltd.

New investment in Lumeon

Magenverkleinerung mit der Handnähmaschine

Nitinotes news paper article


New MTIP investment in Quanta Dialysis Technologies

New investment in Quanta